NHC NATIONAL HEALTHCARE CORP
Services-Skilled Nursing Care Facilities · NYSE · SEC CIK 1047335 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY5.6%
TTM net income YoY13.2%
TTM EPS YoY11.6%
Revenue 3-yr CAGR12.8%
Net income 3-yr CAGR36.8%
Margins
Gross margin—
Operating margin9.8%
Net margin7.2%
FCF margin—
EBITDA margin12.9%
Returns
ROE10.5%
ROA6.3%
ROIC (approx.)9.3%
Asset turnover0.87x
Leverage & solvency
Liabilities / assets45.3%
Debt / equity0.45x
Current ratio1.48x
Interest coverage19.15x
Cash quality & payout
Operating cash flow / net income1.93x
Accruals ratio-5.9%
Payout ratio35.2%
Capex / revenue—
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | 2026Q32026-09-30 | 2026Q22026-06-30 | 2026Q12026-03-31 | 2025Q4*2025-12-31 | 2025Q32025-09-30 | 2025Q22025-06-30 | 2025Q12025-03-31 | 2024Q4*2024-12-31 |
|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||
| Revenue | $407.97M | $408.02M | $381.82M | $386.51M | $382.66M | $374.91M | $373.70M | $369.35M |
| SG&A expense | $8.72M | $8.74M | $5.84M | $27.50T | $8.12M | $8.82M | $6.63M | $6.56M |
| Operating income | $40.63M | $48.94M | $32.25M | $33.12M | $30.38M | $34.09M | $30.77M | $28.91M |
| Interest expense | $6.99M | $13,000 | $269,000 | $816,000 | $1.46M | $1.99M | $2.11M | $2.35M |
| Pretax income | $19.68M | $54.01M | $44.81M | $32.13M | $54.41M | $32.17M | $43.72M | $6.06M |
| Income tax | $5.50M | $13.47M | $8.71M | $6.94M | $13.40M | $8.05M | $11.43M | $28,000 |
| Net income | $13.64M | $40.32M | $35.86M | $24.85M | $39.24M | $23.72M | $32.20M | $6.08M |
| EBITDA | $55.21M | $60.11M | $43.87M | $44.89M | $41.54M | $45.10M | $41.74M | $40.35M |
| EPS (basic) | 0.87 | 2.58 | 2.31 | — | 2.53 | 1.53 | 2.09 | — |
| EPS (diluted) | 0.85 | 2.54 | 2.27 | — | 2.50 | 1.52 | 2.07 | — |
| Dividends declared per share | 0.67 | 0.67 | 0.64 | 0.64 | 0.64 | 0.64 | 0.61 | 0.61 |
| Weighted avg. shares (diluted) | 15.96M | 15.86M | 15.77M | — | 15.66M | 15.60M | 15.58M | — |
| Balance sheet | ||||||||
| Cash & equivalents | $66.80M | $39.21M | $85.53M | $92.83M | $130.63M | $110.99M | $90.39M | $76.12M |
| Receivables | $129.75M | $137.70M | $137.74M | $139.00M | $132.45M | $142.06M | $141.74M | $135.32M |
| Inventory | $8.66M | $8.54M | $9.15M | $7.79M | $7.84M | $7.89M | $8.08M | $9.04M |
| Current assets | $419.83M | $439.60M | $465.58M | $461.82M | $493.52M | $463.23M | $455.20M | $424.41M |
| PP&E, net | $1.29B | $726.77M | $671.82M | $673.80M | $675.17M | $676.62M | $679.45M | $684.29M |
| Goodwill | $170.48M | $170.48M | $170.48M | $170.48M | $170.48M | $170.48M | $170.48M | $170.48M |
| Intangibles | $20.36M | $20.36M | $19.86M | $19.86M | $19.86M | $19.86M | $19.86M | $19.86M |
| Total assets | $2.07B | $1.54B | $1.52B | $1.53B | $1.57B | $1.56B | $1.55B | $1.52B |
| Current liabilities | $283.93M | $236.11M | $250.82M | $253.63M | $282.36M | $268.75M | $239.22M | $234.80M |
| Short-term debt | $23.75M | $0 | $0 | $7.50M | $7.50M | $7.50M | $7.50M | $7.50M |
| Long-term debt | $478.31M | $0 | $0 | $32.50M | $65.62M | $102.50M | $126.50M | $129.50M |
| Total debt | $502.06M | $0 | $0 | $40.00M | $73.12M | $110.00M | $134.00M | $137.00M |
| Total liabilities | $936.98M | $408.87M | $427.48M | $451.90M | $513.91M | $536.84M | $540.84M | $541.27M |
| Shareholders' equity | $1.12B | $1.12B | $1.09B | $1.07B | $1.05B | $1.02B | $1.00B | $980.16M |
| Net debt | $435.27M | -$39.21M | -$85.53M | -$52.83M | -$57.50M | -$992,000 | $43.61M | $60.88M |
| Shares outstanding | 15.66M | 15.66M | 15.61M | 15.54M | 15.52M | 15.50M | 15.46M | 15.45M |
| Cash flow statement | ||||||||
| Operating cash flow | $99.15M | $43.27M | $62.53M | $16.81M | $66.20M | $62.82M | $39.26M | $12.79M |
| Capital expenditure | — | $12.53M | $9.64M | $10.40M | $9.71M | $10.20M | $6.14M | $8.16M |
| Free cash flow | — | $30.74M | $52.89M | $6.41M | $56.49M | $52.62M | $33.12M | $4.63M |
| Investing cash flow | -$556.89M | -$87.67M | -$13.89M | -$12.93M | $1.98M | -$15.58M | -$7.32M | -$11.64M |
| Financing cash flow | $491.78M | -$9.65M | -$54.50M | -$43.22M | -$47.00M | -$33.04M | -$12.69M | -$19.30M |
| Depreciation & amortization | $14.58M | $11.17M | $11.61M | $11.77M | $11.16M | $11.02M | $10.98M | $11.44M |
| Stock-based compensation | $2.02M | $1.99M | $1.28M | $900,000 | $1.24M | $1.23M | $1.03M | $1.10M |
| Dividends paid | $10.49M | $9.99M | $9.94M | $9.93M | $9.92M | $9.43M | $9.42M | $9.42M |
| Share buybacks | $1.11M | $7.24M | $16.32M | $5.16M | $3.18M | $4.66M | $1.72M | $0 |
Free plan shows the latest 8 periods; Pro shows all 66 🔒
· This company does not report gross profit in XBRL.
· Most companies do not report Q4 separately: Q4 = full year − first three quarters (marked *). EPS and share counts cannot be subtracted, so Q4 EPS is often blank; cash flow statements are year-to-date in quarterly reports, so single quarters are mostly derived.
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.